9.20

2.11% 0.19

After Hours: 9.20

Replimune Group Inc (REPL)

Overview News Price History Option Chain Financials Discussions Forecast

Replimune Group Inc stock is traded at $9.20, with a volume of 1.66M. It is up +2.11% in the last 24 hours and up +13.58% over the past month. Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Previous Close:

$9.01

Open:

$8.98

24h Volume:

1.66M

Relative Volume:

0.33

Market Cap:

$721.68M

Revenue:

Net Income/Loss:

$-209.96M

P/E Ratio:

-2.9114

EPS:

-3.16

Net Cash Flow:

$-176.27M

1W Performance:

+2.34%

1M Performance:

+13.58%

6M Performance:

+8.75%

1Y Performance:

-16.74%

1-Day Range:

$8.775

$9.45

1-Week Range:

$8.50

$9.45

52-Week Range:

$2.68

$17.00

Replimune Group Inc Stock (REPL) Company Profile

Name

Replimune Group Inc

Sector

Healthcare (1129)

Industry

Biotechnology (632)

Phone

(781) 222-9600

Address

500 UNICORN PARK, WOBURN, MA

Employee

479

Twitter

@Replimune

Next Earnings Date

2025-02-11

Latest SEC Filings

REPL's Discussions on Twitter

Compare REPL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
REPL Replimune Group Inc	9.20	706.77M	0	-209.96M	-176.27M	-3.16
VRTX Vertex Pharmaceuticals Inc	426.76	107.15B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	755.90	77.46B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	436.38	58.90B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	918.92	56.55B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	198.76	42.58B	447.02M	-1.18B	-906.14M	-6.1812

Replimune Group Inc Stock (REPL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-03-25	Upgrade	BMO Capital Markets	Underperform → Market Perform
Oct-27-25	Upgrade	H.C. Wainwright	Neutral → Buy
Oct-20-25	Upgrade	JP Morgan	Underweight → Neutral
Oct-20-25	Upgrade	Leerink Partners	Market Perform → Outperform
Oct-20-25	Upgrade	Piper Sandler	Neutral → Overweight
Oct-20-25	Upgrade	Wedbush	Neutral → Outperform
Sep-19-25	Downgrade	JP Morgan	Neutral → Underweight
Jul-30-25	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Jul-23-25	Downgrade	BMO Capital Markets	Outperform → Underperform
Jul-23-25	Downgrade	Barclays	Overweight → Equal Weight
Jul-23-25	Downgrade	H.C. Wainwright	Buy → Neutral
Jul-22-25	Downgrade	JP Morgan	Overweight → Neutral
Jul-22-25	Downgrade	Leerink Partners	Outperform → Market Perform
Jul-22-25	Downgrade	Piper Sandler	Overweight → Neutral
Jul-22-25	Downgrade	Wedbush	Outperform → Neutral
Jun-20-25	Initiated	Cantor Fitzgerald	Overweight
Aug-28-24	Initiated	ROTH MKM	Buy
Apr-17-23	Resumed	Piper Sandler	Overweight
Nov-19-21	Initiated	Piper Sandler	Overweight
Oct-15-21	Resumed	BTIG Research	Buy
Nov-17-20	Initiated	BTIG Research	Buy
Nov-02-20	Initiated	Jefferies	Buy
Oct-15-20	Upgrade	H.C. Wainwright	Neutral → Buy
Jul-01-20	Downgrade	H.C. Wainwright	Buy → Neutral
May-05-20	Initiated	Barclays	Overweight
Sep-04-19	Initiated	ROTH Capital	Buy
Jul-23-19	Initiated	Chardan Capital Markets	Buy
Jul-12-19	Upgrade	JP Morgan	Neutral → Overweight
Jul-08-19	Initiated	H.C. Wainwright	Buy
Apr-25-19	Initiated	Wedbush	Outperform
Jan-23-19	Downgrade	JP Morgan	Overweight → Neutral
Aug-14-18	Initiated	JP Morgan	Overweight
Aug-14-18	Initiated	Leerink Partners	Outperform

View All

Replimune Group Inc Stock (REPL) Latest News

Nov 21, 2025

Can One97 Communications Limited Deliver Consistent Free Cash FlowsVolume Spike Alerts & Swing Trade Smarter With Data Insights - earlytimes.in

Nov 21, 2025

Replimune Group Inc. stock volume spike explainedWeekly Stock Analysis & Short-Term Trading Alerts - newser.com

Nov 21, 2025

Nov 20, 2025

How Replimune Group Inc. stock reacts to global recession fearsMarket Trend Review & Smart Investment Allocation Insights - newser.com

Nov 20, 2025

Will Replimune Group Inc. stock deliver shareholder valueQuarterly Trade Summary & Weekly Watchlist for Consistent Profits - newser.com

Nov 20, 2025

Using AI based signals to follow Replimune Group Inc.Bond Market & Long Hold Capital Preservation Tips - newser.com

Nov 20, 2025

Nov 19, 2025

Trend analysis for Replimune Group Inc. this weekWeekly Market Outlook & Low Volatility Stock Suggestions - newser.com

Nov 19, 2025

Replimune Group Executives Sell Shares for Tax Obligations - TradingView

Nov 19, 2025

[Form 4] Replimune Group, Inc. Insider Trading Activity - Stock Titan

Nov 19, 2025

Why Replimune Group Inc. stock is a must watch in 2025July 2025 Levels & Weekly High Momentum Picks - newser.com

Nov 19, 2025

Smart tools for monitoring Replimune Group Inc.’s price actionWeekly Trade Summary & Accurate Entry and Exit Point Alerts - newser.com

Nov 19, 2025